Understand the source comparison
Comparison to liraglutide
Researchers directly compared BRP to liraglutide, another GLP-1 receptor agonist. At equivalent doses (100 mcg/kg), BRP achieved comparable fat mass reduction to liraglutide. Both compounds reduced subcutaneous white adipose tissue, brown adipose tissue mass,
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers directly compared BRP to liraglutide, another GLP-1 receptor agonist. At equivalent doses (100 mcg/kg), BRP achieved comparable fat mass reduction to liraglutide. Both compounds reduced subcutaneous white adipose tissue, brown adipose tissue mass, and liver weight.
- The difference appeared in side effects. Liraglutide-treated animals showed expected gastrointestinal effects. BRP-treated animals did not. This head-to-head comparison strengthens the case that BRP offers similar efficacy with improved tolerability.